Moreover, pre-treating podocytes with recombinant human clusterin protein protects against apoptosis by reducing oxidative stress-induced under diabetic conditions, suggesting a possible therapeutic target for treating DN. The gene discussed is CLU; the disease is liver dysplastic nodule.